Heart Biotech Overview
- Year Founded
-
2014
- Status
-
Private
- Employees
-
5
- Latest Deal Type
-
Later Stage VC
- Latest Deal Amount
-
$2.65M
- Investors
-
4
Heart Biotech General Information
Description
Developer of regenerative implants designed to restore natural tissue function in cardiovascular patients. The company specializes in bioengineered scaffolds featuring cell-free regenerative materials, dynamic tissue-shaping design, and full resorption capability, enabling pediatric and adult patients to regenerate living heart valves that grow, adapt, and eliminate the need for repeat surgeries.
Contact Information
Website
www.heartbiotech.co.ukCorporate Office
- 17 North Drive
- Littleton
- Winchester SO22 6QA
- England, United Kingdom
Corporate Office
- 17 North Drive
- Littleton
- Winchester SO22 6QA
- England, United Kingdom
Heart Biotech Timeline
Heart Biotech Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 6. Later Stage VC | 10-Nov-2025 | $2.65M | Completed | Pre-Clinical Trials | ||
| 5. Grant | 10-Jul-2025 | Completed | Startup | |||
| 4. Grant | 01-Dec-2024 | Completed | Pre-Clinical Trials | |||
| 3. Accelerator/Incubator | 01-Jan-2025 | Completed | Startup | |||
| 2. Later Stage VC | 25-Nov-2024 | $1.54M | $3.75M | Completed | Pre-Clinical Trials | |
| 1. Angel (individual) | 11-Nov-2014 | $2.21M | $2.21M | Completed | Product In Beta Test |
Heart Biotech Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Ordinary | ||||||||
| Ordinary |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
Heart Biotech Comparisons
Industry
Financing
Details
Heart Biotech Competitors (4)
One of Heart Biotech’s 4 competitors is Xeltis, a Venture Capital-Backed company based in Eindhoven, Netherlands.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Xeltis | Venture Capital-Backed | Eindhoven, Netherlands | ||||
| Corcym | Private Equity-Backed | Milan, Italy | ||||
| Edwards Lifesciences | Corporation | Irvine, CA | ||||
| Medtronic | Corporation | Minneapolis, MN |
Heart Biotech Signals
Heart Biotech Investors (4)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| MedTech Innovator | Accelerator/Incubator | |||
| Innovate UK | Government | |||
| Norn Ventures | Venture Capital | Minority | ||
| Sharjah Research Technology and Innovation Park | Corporation | Minority |
Heart Biotech FAQs
-
When was Heart Biotech founded?
Heart Biotech was founded in 2014.
-
Where is Heart Biotech headquartered?
Heart Biotech is headquartered in Winchester, United Kingdom.
-
What is the size of Heart Biotech?
Heart Biotech has 5 total employees.
-
What industry is Heart Biotech in?
Heart Biotech’s primary industry is Biotechnology.
-
Is Heart Biotech a private or public company?
Heart Biotech is a Private company.
-
What is Heart Biotech’s current revenue?
The current revenue for Heart Biotech is .
-
How much funding has Heart Biotech raised over time?
Heart Biotech has raised $6.4M.
-
Who are Heart Biotech’s investors?
MedTech Innovator, Innovate UK, Norn Ventures, and Sharjah Research Technology and Innovation Park have invested in Heart Biotech.
-
Who are Heart Biotech’s competitors?
Xeltis, Corcym, Edwards Lifesciences, and Medtronic are competitors of Heart Biotech.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process